Quantcast

Latest American Society of Clinical Oncology Stories

2014-05-20 23:11:42

Visitors to Miraca Life Science’s tradeshow booth #8123 can learn about new technology partnerships and product offerings. Irving, Texas (PRWEB) May 20, 2014 Miraca Life Sciences, (MLS) the nation’s largest independent anatomic pathology lab, will announce new services for oncology practices at the 50th annual meeting of the American Society of Clinical Oncology (ASCO). Visitors to Miraca Life Science’s tradeshow booth #8123 can learn about new technology partnerships and product...

2014-05-15 08:31:40

Comprehensive Molecular Profiling Provides Oncologists Treating Patients with Rare, Aggressive or Refractory Cancers with Better Understanding of How to Treat Cancer IRVING, Texas, May 15, 2014 /PRNewswire/ -- Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of precision medicine, today announced the acceptance of 34 key clinical studies by the American Society of Clinical Oncology (ASCO) for their 50(th) annual meeting to be held May 30 through June 3 in...

2014-05-14 16:29:17

DecisionDx-Melanoma identifies patients with negative sentinel lymph node biopsies who are at high risk of metastasis FRIENDSWOOD, Texas, May 14, 2014 /PRNewswire/ -- Castle Biosciences Inc. announced today that abstracts reporting additional clinical validation data for two of its molecular tests -- one focused on melanoma and the other on esophageal adenocarcinoma -- will be presented at the 50(th) Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 30-June 3,...

2014-05-14 08:30:37

BOULDER, Colo., May 14, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced presentations on its MEK inhibitors, binimetinib (MEK162) (co-developing with Novartis) and selumetinib (licensed to AstraZeneca) at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 30 - June 3, 2014 in Chicago, Illinois. Both MEK inhibitors are advancing in Phase 3 or pivotal trials: binimetinib is being evaluated in NRAS- and BRAF-mutant...

2014-05-08 23:15:38

In CHAMPS Oncology's most recent blog post, “Q” is for Quality (and QOPI Certification), Melissa Smith shares her thoughts on the topic. Cleveland, OH (PRWEB) May 08, 2014 In CHAMPS Oncology's most recent blog post, “Q” is for Quality (and QOPI Certification), Melissa Smith shares her thoughts on the topic. Smith explains that the quality of care a cancer patient receives is crucial to their survival. That’s why administrators and clinicians implement patient-centered...

2014-05-06 23:06:23

Expands Relationship of Innovation and Efficiencies (PRWEB) May 06, 2014 Florida Cancer Specialists & Research Institute (FCS), one of the largest cancer care providers in the United States, announced it will now be sourcing all of its chemotherapeutic and supportive therapy products from Oncology Supply. The agreement will go into effect immediately. "We're very pleased with the new contract and continuing our long-term partnership with Oncology Supply and International...

2014-05-06 16:32:12

Guest Speakers to Discuss Calmare® Pain Device Therapy Treatment; Company Developed Medical Milestones and Advancements to be Disclosed FAIRFIELD, Conn., May 6, 2014 /PRNewswire/ -- Competitive Technologies, Inc., (CTI), the pain mitigation company, will host a private engagement for top opinion leaders in oncology at the Hyatt Regency McCormick Place on June 1, 2014 during the 50(th) Annual American Society of Clinical Oncology (ASCO) in Chicago, IL....

2014-04-21 16:25:24

LOS ANGELES, April 21, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that the abstract describing the Company's phase II trial of dendritic cell-based cancer vaccine ICT-107 in newly diagnosed glioblastoma (GBM) has been accepted for an oral presentation at the 2014 American Society for Clinical Oncology (ASCO) annual meeting, to be held in Chicago May 30-June 3, 2014....

2014-03-31 23:24:01

Mediaplanet’s campaign sheds light on advancements in treatment and technology of cancer care in the 21st century, providing a special focus on breast cancer awareness and advocacy. San Francisco, CA (PRWEB) March 31, 2014 “Innovations in Cancer Care”, a cross-platform awareness campaign produced by Mediaplanet, launches today as a 12-page print publication within the San Francisco Chronicle and as a site distributed across a network of online platforms. The campaign will reach over...

2014-03-26 23:03:41

Doctors and Cancer Organizations Call Cancer Peace Portal ‘Revolutionary’ Vancouver, WA (PRWEB) March 26, 2014 On March 26th Help4Cancer.net launches a crowd funding campaign to raise awareness and $239,000 for its new Cancer Peace Portal. Cancer Peace Portal is a one of a kind multi-faceted strategy to offer cancer patients and those who support them a central resource for information, hope, peace and better living strategies. Sue Sumpter, Senior Manager of the Leukemia and...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related